The Trump administration has authorized a test program to see if the cannabis compound can ease some symptoms and reduce health care costs among older patients.
Category: Medicare
-
Some Medicare Patients Can Now Get Free CBD
The New York Times – Business: -
Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
The New York Times – Business:What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss.
-
Trump Administration Will Withhold $1.3 Billion in Medicaid Payments to California
The New York Times – Business:Vice President JD Vance said the state had not done enough to fight fraud in the public health insurance program.
-
UnitedHealth Group Reports Flat First-Quarter Earnings
The New York Times – Business:One of the nation’s largest insurers, the company’s profits were higher than analysts’ expectations but still fell short of showing a significant comeback.
-
Help for Medicare Advantage Patients Who Lose Doctors Is Shelved, for Now
The New York Times – Business:Nationwide, hospital and providers are leaving private Medicare Advantage plans, putting thousands of seniors at risk of higher costs and the loss of trusted doctors.
-
When Changing Your Address Leads to Losing Your Medicare Coverage
The New York Times – Business:Using a post office box shouldn’t cost you your health insurance. But in one woman’s case, it sure seemed to.
-
Kaiser Permanente Agrees to Pay $556 Million to Settle Medicare Overbilling Claims
The Justice Department and whistle-blowers accused the major health insurer of overbilling the government for about $1 billion under the private plans.
-
Retirement 2026 by the Numbers
As the new year begins, savings have hit unprecedented levels, but rising health care costs and growing poverty make retirement unaffordable for many.
-
U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent.